Compare STOK & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | ANDE |
|---|---|---|
| Founded | 2014 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2019 | 2005 |
| Metric | STOK | ANDE |
|---|---|---|
| Price | $32.81 | $73.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $39.20 | ★ $75.00 |
| AVG Volume (30 Days) | ★ 795.5K | 297.0K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | ★ 92.73 | 12.93 |
| EPS | N/A | ★ 0.82 |
| Revenue | $184,420,000.00 | ★ $11,008,928,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | $82.05 | $3.57 |
| P/E Ratio | ★ N/A | $87.78 |
| Revenue Growth | ★ 404.50 | N/A |
| 52 Week Low | $5.35 | $31.03 |
| 52 Week High | $40.22 | $73.97 |
| Indicator | STOK | ANDE |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 63.62 |
| Support Level | $31.02 | $62.29 |
| Resistance Level | $35.75 | N/A |
| Average True Range (ATR) | 2.42 | 2.56 |
| MACD | -0.29 | 0.29 |
| Stochastic Oscillator | 28.66 | 89.86 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.